161 related articles for article (PubMed ID: 7503695)
1. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.
Dunn SJ; Fiore L; Werner RL; Cross TL; Broome RL; Ruggeri FM; Greenberg HB
Arch Virol; 1995; 140(11):1969-78. PubMed ID: 7503695
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.
Padilla-Noriega L; Fiore L; Rennels MB; Losonsky GA; Mackow ER; Greenberg HB
J Clin Microbiol; 1992 Jun; 30(6):1392-7. PubMed ID: 1320626
[TBL] [Abstract][Full Text] [Related]
3. Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4.
Patton JT; Hua J; Mansell EA
J Virol; 1993 Aug; 67(8):4848-55. PubMed ID: 8392619
[TBL] [Abstract][Full Text] [Related]
4. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin.
Fiore L; Greenberg HB; Mackow ER
Virology; 1991 Apr; 181(2):553-63. PubMed ID: 1849677
[TBL] [Abstract][Full Text] [Related]
5. Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge.
Mackow ER; Vo PT; Broome R; Bass D; Greenberg HB
J Virol; 1990 Apr; 64(4):1698-703. PubMed ID: 2157052
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
[TBL] [Abstract][Full Text] [Related]
8. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells.
Zárate S; Espinosa R; Romero P; Méndez E; Arias CF; López S
J Virol; 2000 Jan; 74(2):593-9. PubMed ID: 10623720
[TBL] [Abstract][Full Text] [Related]
9. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus.
Fiore L; Dunn SJ; Ridolfi B; Ruggeri FM; Mackow ER; Greenberg HB
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1981-8. PubMed ID: 7636478
[TBL] [Abstract][Full Text] [Related]
10. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.
Dormitzer PR; Greenberg HB; Harrison SC
J Virol; 2001 Aug; 75(16):7339-50. PubMed ID: 11462006
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
Ruggeri FM; Greenberg HB
J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
[TBL] [Abstract][Full Text] [Related]
14. Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3.
Padilla-Noriega L; Dunn SJ; López S; Greenberg HB; Arias CF
Virology; 1995 Jan; 206(1):148-54. PubMed ID: 7530390
[TBL] [Abstract][Full Text] [Related]
15. The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant.
Mackow ER; Barnett JW; Chan H; Greenberg HB
J Virol; 1989 Apr; 63(4):1661-8. PubMed ID: 2538649
[TBL] [Abstract][Full Text] [Related]
16. Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.
Larralde G; Li BG; Kapikian AZ; Gorziglia M
J Virol; 1991 Jun; 65(6):3213-8. PubMed ID: 1709699
[TBL] [Abstract][Full Text] [Related]
17. Trypsin activation pathway of rotavirus infectivity.
Arias CF; Romero P; Alvarez V; López S
J Virol; 1996 Sep; 70(9):5832-9. PubMed ID: 8709201
[TBL] [Abstract][Full Text] [Related]
18. Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4.
Larralde G; Gorziglia M
J Virol; 1992 Dec; 66(12):7438-43. PubMed ID: 1279204
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4.
Ijaz MK; Nur-E-Kamal MS; Dar FK; Uduman S; Redmond MJ; Attah-Poku SK; Dent D; Babiuk LA
Vaccine; 1998; 16(9-10):916-20. PubMed ID: 9682337
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse.
Bass DM; Baylor M; Broome R; Greenberg HB
J Clin Invest; 1992 Jun; 89(6):1741-5. PubMed ID: 1318323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
